Devyser Diagnostics AB (publ) (STO:DVYSR)
Sweden
· Delayed Price · Currency is SEK 128.50
0.00 (0.00%)
Feb 21, 2025, 5:29 PM CET
Devyser Diagnostics AB Revenue
In the year 2024, Devyser Diagnostics AB had annual revenue of 216.90M SEK with 28.12% growth. Devyser Diagnostics AB had revenue of 64.20M in the quarter ending December 31, 2024, with 41.41% growth.
Revenue
216.90M
Revenue Growth
+28.12%
P/S Ratio
9.71
Revenue / Employee
1.82M
Employees
119
Market Cap
2.13B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.03B |
| Getinge AB | 34.76B |
| Sectra AB | 3.14B |
| Camurus AB | 1.87B |
| Medicover AB | 23.97B |
| Vitrolife AB | 3.61B |
| Elekta AB | 17.88B |
| Vimian Group AB | 4.29B |